Roberts Glore & Co. Inc. IL Has $1.47 Million Position in Centene Corporation $CNC

Roberts Glore & Co. Inc. IL increased its holdings in shares of Centene Corporation (NYSE:CNC) by 42.9% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 41,159 shares of the company’s stock after purchasing an additional 12,362 shares during the period. Roberts Glore & Co. Inc. IL’s holdings in Centene were worth $1,469,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of the stock. MAI Capital Management raised its position in shares of Centene by 6.3% in the third quarter. MAI Capital Management now owns 6,545 shares of the company’s stock valued at $234,000 after buying an additional 388 shares in the last quarter. Waddell & Associates LLC raised its stake in Centene by 117.0% during the third quarter. Waddell & Associates LLC now owns 11,616 shares of the company’s stock worth $414,000 after acquiring an additional 6,263 shares in the last quarter. Optiver Holding B.V. bought a new position in Centene in the 3rd quarter valued at approximately $145,000. Counterpoint Mutual Funds LLC boosted its holdings in shares of Centene by 161.1% during the 3rd quarter. Counterpoint Mutual Funds LLC now owns 91,943 shares of the company’s stock valued at $3,281,000 after acquiring an additional 56,730 shares in the last quarter. Finally, Mufg Securities Americas Inc. grew its holdings in shares of Centene by 14.1% during the third quarter. Mufg Securities Americas Inc. now owns 12,582 shares of the company’s stock worth $449,000 after purchasing an additional 1,554 shares during the last quarter. 93.63% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. JPMorgan Chase & Co. raised their target price on Centene from $38.00 to $45.00 and gave the stock a “neutral” rating in a research report on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Centene from $32.00 to $39.00 and gave the company a “hold” rating in a research note on Tuesday, February 10th. UBS Group set a $42.00 target price on Centene and gave the stock a “neutral” rating in a report on Thursday, October 30th. Wall Street Zen downgraded Centene from a “buy” rating to a “hold” rating in a research note on Sunday, February 15th. Finally, Robert W. Baird increased their target price on shares of Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Three research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, Centene has a consensus rating of “Hold” and a consensus price target of $42.00.

Centene Price Performance

Shares of NYSE CNC opened at $42.71 on Thursday. The stock has a fifty day moving average of $42.64 and a 200-day moving average of $37.31. Centene Corporation has a fifty-two week low of $25.08 and a fifty-two week high of $66.03. The stock has a market cap of $21.00 billion, a PE ratio of -3.14, a price-to-earnings-growth ratio of 0.94 and a beta of 0.48. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.10 and a current ratio of 1.10.

Centene (NYSE:CNC) last released its quarterly earnings data on Friday, February 6th. The company reported ($1.19) EPS for the quarter, beating analysts’ consensus estimates of ($1.22) by $0.03. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The company had revenue of $49.73 billion during the quarter, compared to analyst estimates of $48.41 billion. During the same period last year, the business earned $0.80 earnings per share. Centene’s revenue was up 21.9% compared to the same quarter last year. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Equities research analysts anticipate that Centene Corporation will post 6.86 earnings per share for the current year.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.